|
Dr. Zeldis is Chief Medical Officer of Celgene Corporation, Warren, NJ. He is currently Professor of Clinical Medicine at the Robert Wood Johnson Medical School in New Brunswick, New Jersey. Prior to working at Celgene, Dr. Zeldis worked at Sandoz Research Institute and Janssen Research Institute in both clinical research and medical development. He has been a board member of a few start-up biotechnology companies and is currently on the board of the Semorex Corporation, ImmuneRegen, the NJ Chapter of the Arthritis Foundation and the Castleman’s Disease Organization. He currently has published 95 peer reviewed articles and 24 reviews, book chapters, and editorials. | 